Maternal to fetal thyroxine transmission in the human term placenta is limited by inner ring deiodination

被引:85
作者
Mortimer, RH
Galligan, JP
Cannell, GR
Addison, RS
Roberts, MS
机构
[1] ROYAL BRISBANE HOSP, CONJOINT ENDOCRINE LAB, BRISBANE, QLD 4029, AUSTRALIA
[2] ROYAL BRISBANE HOSP, DEPT CHEM PATHOL, BRISBANE, QLD 4029, AUSTRALIA
关键词
D O I
10.1210/jc.81.6.2247
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Placental deiodination of T-4 to rT(3) has been proposed as the factor controlling materno-fetal transmission of T-4. We investigated T-4 transfer in the isolated perfused human placental lobule with and without addition of the deiodinase inhibitor, iopanoic acid. T-4 (150 nnol/L) in protein-free medium was added to the maternal circuit. Without iopanoic acid, the appearance of T-4 in the fetal circuit was very low, with fetal T-4 levels reaching only 4.1 +/- 0.04 pmol/L at 6 h. Levels of rT, rose progressively in both circuits, reaching 28.8 +/- 5.5 nmol/L in the maternal and 12.4 +/- 3.2 nmol/L in the fetal circuit by 6 h. No T-3 could be measured in either circuit. Addition of 0.5 mmol/L iopanoic acid to maternal perfusate, however, resulted in significant reduction in the appearance of rT(3) [maternal levels, 0.58 +/- 0.06 nmol/L (2% of control values); fetal levels, 0.33 +/- 0.03 mmol/L (2.7% of control values)] and a major (similar to 2700-fold) increase in T-4 appearance in the fetal circuit, with fetal T-4 levels reaching 10.1 +/- 3.4 nmol/L at 6 h. These results support the hypothesis that placental inner ring (type III) deiodination is a major factor controlling placental transmission of maternal T-4.
引用
收藏
页码:2247 / 2249
页数:3
相关论文
共 20 条
[1]   CONVERSION OF THYROXINE TO TRIIODOTHYRONINE AND REVERSE TRIIODOTHYRONINE IN HUMAN-PLACENTA AND FETAL MEMBRANES [J].
BANOVAC, K ;
BZIK, L ;
TISLARIC, D ;
SEKSO, M .
HORMONE RESEARCH, 1980, 12 (05) :253-259
[2]  
BURROW GN, 1994, NEW ENGL J MED, V331, P1072
[3]   MARKERS OF PHYSICAL INTEGRITY AND METABOLIC VIABILITY OF THE PERFUSED HUMAN PLACENTAL LOBULE [J].
CANNELL, GR ;
KLUCK, RM ;
HAMILTON, SE ;
MORTIMER, RH ;
HOOPER, WD ;
DICKINSON, RG .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1988, 15 (11) :837-844
[4]  
CARR EA, 1959, J CLIN ENDOCR METAB, V19, P1
[5]   INNER-RING DEIODINATION OF 3,5,3'-TRIIODOTHYRONINE IN THE INSITU PERFUSED GUINEA-PIG PLACENTA [J].
CASTRO, MI ;
BRAVERMAN, LE ;
ALEX, S ;
WU, CF ;
EMERSON, CH .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) :1921-1926
[6]   CONVERSION OF THYROXINE TO 3,3',5'-TRIIODOTHYRONINE IN THE GUINEA-PIG PLACENTA - INVIVO STUDIES [J].
COOPER, E ;
GIBBENS, M ;
THOMAS, CR ;
LOWY, C ;
BURKE, CW .
ENDOCRINOLOGY, 1983, 112 (05) :1808-1815
[7]  
DIXON WJ, 1992, ANOVA REGRESSION BMD
[8]  
DUSSAULT JH, 1968, J CLIN ENDOCR METAB, V29, P595
[9]   THE EFFECT OF THYROID-DYSFUNCTION AND FASTING ON PLACENTA INNER RING DEIODINASE ACTIVITY IN THE RAT [J].
EMERSON, CH ;
BAMBINI, G ;
ALEX, S ;
CASTRO, MI ;
ROTI, E ;
BRAVERMAN, LE .
ENDOCRINOLOGY, 1988, 122 (03) :809-816
[10]   THE EFFECTS OF PROPYLTHIOURACIL, IODOTHYRONINES, AND OTHER AGENTS ON THYROID-HORMONE METABOLISM IN HUMAN-PLACENTA [J].
FAY, M ;
ROTI, E ;
SHIH, LF ;
WRIGHT, G ;
BRAVERMAN, LE ;
EMERSON, CH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (02) :280-286